Table 1.
List of HTA agencies/organizations belonging to INAHTA, HTAi and EUnetHTA network, and public-private partners of EUnetHTA and its JA, which have been consulted.
| Country | HTA agency/organization | INAHTA | HTAi | EUnetHTA |
|---|---|---|---|---|
| Argentina | IECS—Institute for Clinical Effectiveness and Health Policy | x | ||
| Australia | AHTA—Adelaide Health Technology Assessment | x | x | |
| ASERNIP-S—Australian Safety and Efficacy Register of New Interventional | x | |||
| Procedures—Surgical | ||||
| PBAC&MSAC—Pharmaceutical Benefits Advisory Committee | x | |||
| Austria | AIHTA—Austrian Institute for Health Technology Assessment | x | x | |
| UMIT—University for Health Sciences, Medical Informatics and Technology | x | |||
| GOG—Gesundheit Österreich GmbH/Geschäftsbereich | x | x | ||
| HVB—Hauptverband der Österreichischen Sozialversicherungsträger (Association of Austrian Social Insurance Institutions) | x | |||
| Belgium | KCE—Belgian Health Care Centre | x | x | |
| IPH—Scientific Institute of Public Health RIZIV—INAMI- Rijksinstituut voor Ziekte- en Invaliditeitsverzekering |
x x |
|||
| Brazil | ANS—National Regulatory Agency for Private Health Insurance and Plans | x | ||
| CONITEC—National Committee for Technology Incorporation | x | x | ||
| MoH—Ministry of Health of Brazil | x | |||
| Bulgaria | NCPHA—National Center of Public Health and Analyses | x | ||
| Canada | CADTH—Canadian Agency for Drugs and Technologies in Health | x | x | |
| IHE—Institute of Health Economics | x | x | ||
| INESS—Institut national d'excellence en santé et en services sociaux* | x | |||
| OH—Ontario Health | x | |||
| China | CDE—Center for Drug Evaluation, Taiwan | x | ||
| Colombia | IETS—Instituto de Evaluación Tecnológica en Salud | x | ||
| Croatia | MIZ—Ministry of Health of the Republic of Croatia | x | ||
| CHIF—Croatian Health Insurance Fund | x | |||
| CIPH—Croatian Institute of Public Health | x | |||
| Cyprus | MoH Cyprus—Ministry of Health of Cyprus | x | ||
| Czech Republic | MoH Czech—Ministry of Health of the Czech Republic | x | ||
| SUKL—State Institute for Drug Control | x | |||
| Denmark | DEFACTUM (formerly CFK) | x | x | |
| Estonia | UTA—Institute of Family Medicine and Public Health | x | ||
| Finland | FinCCHTA—Finnish Coordinating Center for Health Technology Assessment | x | x | x |
| FIMEA—Finnish Medicines Agency | x | |||
| THL—National Institute for Health and Welfare | x | |||
| France | HAS—French National Authority for Health (Haute Autorité de Santé) | x | x | x |
| AP-HP—Assistance publique- Hopitaux de Paris, FRANCE | x | |||
| Germany | DIMDI—German Institute for Medical Documentation and Information | x | ||
| GBA—Gemeinsamer Bundesausschuss | x | x | ||
| IQWIG—Institute for Quality and Efficiency in Health Care | x | x | ||
| Greece | EKAPTY-NKUA—National and Kapodistrian University of Athens | x | ||
| EKAPTY SA—National Evalution Center of Quality and Technology in S.A.- | x | |||
| EOF—National Organization for Medicines | x | |||
| EOPYY—National Organisation for Healthcare Provision | x | |||
| IFET—Institute of Pharmaceutical Research and Technology | x | |||
| OCSC—Onassis Cardiac Surgery Centre | x | |||
| Hungary | NIPN—National Institute of Pharmacy and Nutrition | x | ||
| SU—Health Services Management Training Center | x | |||
| Indonesia | CEEBM Center for Clinical Epidemiology-Evidence Based Medicine at Cipto Mangunkusumo Hospital | x | ||
| Ireland | HIQA—Health Information and Quality Authority | x | x | x |
| NCPE—National Centre for Pharmacoeconomics, St. James Hospital | x | |||
| Italy | AGENAS—National Agency for Regional Health Services | x | x | |
| UCSC Gemelli- University Hospital A. Gemelli | x | x | ||
| AIFA—Italian Medicines Agency | x | x | ||
| CRUF/AOUIVR—Centro Regionale Unico sul Farmacia del Veneto | x | |||
| DGFDM IT—Sede del Ministro–Ministero della salute | x | |||
| RER—Regione Emilia-Romagna | x | |||
| UVTA/AOP—Unita di Valutazione Technology Assessment | x | |||
| Veneto/CRUF—Regione Del Veneto–Area Sanità e Sociale | x | |||
| Kazakhstan | SK-NRCHD—Salidat Kairbekova National Research Center for Health Development* | x | ||
| Korea | NECA—National Evidence-based healthcare Collaborating Agency* | x | x | |
| Latvia | NVD—National Health Service | x | ||
| Lithuania | HI—The Institute of Hygiene | x | ||
| VASPVT—State Health Care Accreditation Agency | x | |||
| VVKT—State Medicines Control Agency of Lithuania | x | |||
| Malaysia | MaHTAS—Health Technology Assessment Section, Ministry of Health Malaysia* | x | x | |
| Malta | DPA/MoH Malta—Directorate for Pharmaceutical Affairs | x | ||
| Netherlands | EUR—Erasmus Universiteit Rotterdam | x | ||
| UU—Utrecht University | x | |||
| ZIN—National Health Care Institute | x | x | x | |
| ZonMw—The Netherlands Organisation for Health Research and Development* | x | |||
| Norway | NIPH—Norwegian Institute of Public Health | x | ||
| HDIR—Norwegian Directorate of Health | x | |||
| NIPHNO (formerly NOKC) —The Norwegian Institute of Public Health | x | x | ||
| NOMA—Norwegian Medicines Agency | x | |||
| Norwegian Centre for E-health Research | x | |||
| Peru | IETSI—Institute of Health Technology Assessment and Research | x | ||
| Poland | AOTMiT—Agency for Health Technology Assessment and Tariff System | x | x | |
| Portugal | ACSS IP—Administração Central do Sistema de Saúde, I.P. | x | ||
| INFARMED—National Authority of Medicines and Health Products | x | |||
| Romania | NIPHB—Institutu National De Sanatate Publica (INSP) | x | ||
| NSPHMPDB—National School of Public Health, Management and Professional | x | |||
| Development | ||||
| UBB—Babes-bolayi University, Cluj School of Public Health | x | |||
| Russian Federation | CHQA—Center for Healthcare Quality Assessment and Control | x | ||
| HTA Association | x | |||
| Singapore | ACE—Agency for Care Effectiveness | x | ||
| Slovakia | MoH Slovak Republic—Ministry of Health of the Slovak Republic | x | ||
| UniBA FOF—Comenius University in Bratislava | x | |||
| Slovenia | JAZMP—Public Agency of the Republic of Slovenia for Medicinal Products and | x | ||
| Medical Devices | ||||
| MoH Slovenia—Ministry of Health of the Republic of Slovenia | x | |||
| NIJZ—National institute of Public Health (NIJZ) | x | |||
| Spain | AEMPS—Agencia Española de Medicamentos y Productos Sanitarios | x | ||
| AETS-ISCIII—The Instituto De Salud Carlos III | x | |||
| AETSA—Andalusian HTA Agency | x | x | x | |
| AquAS—Agency for Health Quality and Assessment of Catalonia | x | x | ||
| AVALIA FNS—Fundacion Profesor Novoa Santos AVALIA-T—Galician Agency for HTA |
x | x | x x |
|
| BIOEF—Basque Foundation for Health Innovation and Research | x | |||
| DGFPS MSPSI-Directorate General for Pharmacy and Health Care Products | x | |||
| FPS—Fundación Pública Andaluza Progreso y Salud | x | |||
| FUNCANIS—Fundación Canaria de Investigación Sanitaria | x | |||
| IACS—Health Sciences Institute in Aragon, SPAIN | x | |||
| OSTEBA—Basque Office for Health Technology Assessment- Ministry for Health | x | x | x | |
| SESCS—Evaluation AND Planning Unit–Directorate of the Canary Islands Health Service | x | |||
| Sweden | SBU—Swedish Agency for Health Technology Assessment and Assessment of | x | x | |
| Social Services | ||||
| MPA—Medical Products Agency | x | |||
| TLV—Dental and Pharmaceutical Benefits Agency | x | x | ||
| Switzerland | SNHTA—Swiss Network for HTA | x | ||
| SFOPH—Swiss Federal Office of Public Health* | x | x | ||
| Tunisia | INEAS—National Authority for Assessment and Accreditation in Healthcare* | x | x | |
| Ukraine | MoH Ukraine—HTA Department of SEC of Ministry of Health of Ukraine* | x | x | |
| United Kingdom | HTW—Health Technology Wales | x | x | |
| HIS—Healthcare Improvement Scotland | x | x | x | |
| NICE—National Institute for Health and Care Excellence | x | x | x | |
| NIHR—National Institute for Health Research* | x | |||
| AWTTC—All Wales Therapeutics and Toxicology Centre | x | x | x | |
| United States | AHRQ—Agency for Healthcare Research and Quality | x | x | |
| Blue Cross Blue Shield Association | x | |||
| CMTP—Center for Medical Technology Policy | ||||
| ICER—Institute for Clinical and Economic Review | x | |||
| Kaiser Permanente | x | |||
| PCORI—Patient-Centered Outcomes Research Institute (USA) | x | |||
| Uruguay | HAD—Health Assessment Division, Ministry of Public Health | x | ||
| HAD—Health Assessment Division, Ministry of Public Health | x | |||
| EUnetHTA JA2 | x | |||
| Joint Action (JA) and public-private partners of EUnetHTA | ||||
| European Union | IMI—Innovative Medicines Initiative | x | ||
| ISPOR—International Society for Pharmacoeconomics and Outcomes Research | x | |||
*
Websites not available.